Table 1. Analysis of ALDH activity and/or CD133 cell surface expression in different generations of direct pancreatic cancer xenograft tumors.
| Patient/ treatment status | Xenograft generation | ALDHlow/CD133− | ALDHlow/CD133+ | ALDHhigh/CD133− | ALDHhigh/CD133+ |
| MDA-PATX5 | F2 | 68.5 | 26.1 | 3.1 | 0.8 |
| untreated | F2 | 49.32 | 45.6 | 2.6 | 1.32 |
| F3 | 43.8 | 46.8 | 5.4 | 2.54 | |
| F3 | 41.3 | 49 | 6.9 | 2.7 | |
| F3 | - | - | 4.6 | - | |
| F3 | 59.2 | 37.8 | 1.8 | 0.9 | |
| F4 | - | - | 4 | - | |
| F4 | - | 15.5 | 2 | - | |
| F4 | 76.7 | 21.6 | 2.1 | 0.4 | |
| F4 | 86.9 | 12.6 | 0.4 | 0.1 | |
| F4 | 88.4 | 9.7 | 1.8 | 0.1 | |
| F4 | 87.9 | 8.3 | 3.6 | 0.1 | |
| F4 | 69.5 | 27.8 | 2 | 0.7 | |
| F4 | 73.6 | 23.7 | 2 | 0.6 | |
| F4 | - | 6.8 | 2.3 | - | |
| MDA-PATX1 | F2 | 43.1 | 8.5 | 42.9 | 5.5 |
| untreated | F2 | 65.2 | 4.5 | 29.1 | 1.21 |
| F3 | 71.3 | 0.9 | 27.7 | 0.1 | |
| F3 | 63.5 | 0.9 | 35.5 | 0.1 | |
| MDA-PATX13 | F1 | 55.4 | 16.8 | 22.3 | 5.5 |
| treated | F1 | 67.9 | 17.7 | 11.3 | 3.1 |
| F2 | 50.1 | 28.7 | 18.3 | 2.9 | |
| F4 | 65.5 | 20.9 | 12.5 | 1.1 | |
| MDA-PATX2 | F2 | 48.3 | 31.2 | 13.2 | 6.3 |
| untreated | F3 | 37.9 | 29.2 | 26.5 | 6.4 |
| F3 | 20.8 | 40.8 | 26.4 | 12 | |
| MDA-PATX10 | F1 | 97.9 | 0.1 | 2 | 0.01 |
| treated | F2 | - | - | 15.2 | - |
| MDA-PATX9 | F1 | 74.6 | 2.7 | 22.6 | 0.1 |
| treated |